Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, DIBIT, San Raffaele Scientific Institute, Milan, Italy.
AIDS. 2010 Oct 23;24(16):2527-33. doi: 10.1097/QAD.0b013e32833d7d8c.
CCR5-using HIV-1 (R5 viruses) are usually isolated during acute infection from both adults and children. We have recently demonstrated that R5 viruses with a flexible use of CCR5 (called R5broad) can be detected in children close to birth and are predictive of a fast immunological failure. The aim of the present work was to investigate viral phenotype variation during disease progression in HIV-1 infected children, six slow and eight fast progressors.
A total of 74 viral isolates obtained sequentially from 14 HIV-1 infected children were tested for their ability to infect U87.CD4 cells expressing a set of six different CCR5/CXCR4 chimeric receptors or wild-type coreceptors. The sensitivity of 35 R5 viruses to inhibition with the CC-chemokine RANTES (regulated upon activation, normal T-cell expressed and secreted) was evaluated in a peripheral blood mononuclear cells based assay.
Viral evolution to R5broad or to R5X4 phenotype occurred with one exception, in all children, although at a different time point according to rate of disease progression. Immune deficiency in the children was significantly associated with the appearance of R5broad phenotype or R5X4 viruses. Analysis of the sensitivity to inhibition by RANTES revealed a significant correlation between the R5broad phenotype and an augmented resistance to this CC-chemokine.
We demonstrate that the viral evolution to a more flexible CCR5-use is sufficient to explain the immunological failure in the absence of CXCR4 usage. These results warrant detailed analysis of the R5 phenotype in forthcoming clinical studies introducing CCR5 inhibitors for the treatment of pediatric HIV-1 infection.
在急性感染期间,通常会从成人和儿童中分离出使用 CCR5 的 HIV-1(R5 病毒)。我们最近证明,在接近出生的儿童中可以检测到具有灵活使用 CCR5 的 R5 病毒(称为 R5broad),并且可以预测快速免疫失败。本研究的目的是研究 HIV-1 感染儿童在疾病进展过程中病毒表型的变化,包括 6 例缓慢进展者和 8 例快速进展者。
总共从 14 名 HIV-1 感染儿童中连续获得了 74 个病毒分离物,以测试它们感染表达一组六种不同 CCR5/CXCR4 嵌合受体或野生型核心受体的 U87.CD4 细胞的能力。在基于外周血单核细胞的测定中,评估了 35 个 R5 病毒对 CC-趋化因子 RANTES(激活后调节,正常 T 细胞表达和分泌)抑制的敏感性。
除了一个例外,所有儿童的病毒都进化为 R5broad 或 R5X4 表型,尽管根据疾病进展速度在不同时间点出现。儿童的免疫缺陷与 R5broad 表型或 R5X4 病毒的出现显著相关。对 RANTES 抑制敏感性的分析表明,R5broad 表型与对这种 CC-趋化因子的增强抗性之间存在显著相关性。
我们证明,向更灵活的 CCR5 使用的病毒进化足以解释在没有 CXCR4 使用的情况下免疫失败。这些结果证明,在即将进行的引入 CCR5 抑制剂治疗儿科 HIV-1 感染的临床研究中,需要对 R5 表型进行详细分析。